• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of the Egyptian Society of Parasitology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 50 (2020)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 49 (2019)
Volume Volume 48 (2018)
Volume Volume 47 (2017)
Volume Volume 46 (2016)
Volume Volume 45 (2015)
Volume Volume 44 (2014)
Volume Volume 43 (2013)
ELGENDY, D., OTHMAN, A., EL-GUINDY, D., SOLIMAN, N., ELMEHY, D. (2020). SYNERGY BETWEEN BETA-1, 3-GLUCAN AND PRAZIQUANTEL IN THE TREATMENT OF EXPERIMENTAL CHRONIC SCHISTOSOMIASIS MANSONI. Journal of the Egyptian Society of Parasitology, 50(3), 565-574. doi: 10.12816/jesp.2020.131088
DINA I. ELGENDY; AHMAD A. OTHMAN; DINA M. EL-GUINDY; NEMA A. SOLIMAN; DALIA A. ELMEHY. "SYNERGY BETWEEN BETA-1, 3-GLUCAN AND PRAZIQUANTEL IN THE TREATMENT OF EXPERIMENTAL CHRONIC SCHISTOSOMIASIS MANSONI". Journal of the Egyptian Society of Parasitology, 50, 3, 2020, 565-574. doi: 10.12816/jesp.2020.131088
ELGENDY, D., OTHMAN, A., EL-GUINDY, D., SOLIMAN, N., ELMEHY, D. (2020). 'SYNERGY BETWEEN BETA-1, 3-GLUCAN AND PRAZIQUANTEL IN THE TREATMENT OF EXPERIMENTAL CHRONIC SCHISTOSOMIASIS MANSONI', Journal of the Egyptian Society of Parasitology, 50(3), pp. 565-574. doi: 10.12816/jesp.2020.131088
ELGENDY, D., OTHMAN, A., EL-GUINDY, D., SOLIMAN, N., ELMEHY, D. SYNERGY BETWEEN BETA-1, 3-GLUCAN AND PRAZIQUANTEL IN THE TREATMENT OF EXPERIMENTAL CHRONIC SCHISTOSOMIASIS MANSONI. Journal of the Egyptian Society of Parasitology, 2020; 50(3): 565-574. doi: 10.12816/jesp.2020.131088

SYNERGY BETWEEN BETA-1, 3-GLUCAN AND PRAZIQUANTEL IN THE TREATMENT OF EXPERIMENTAL CHRONIC SCHISTOSOMIASIS MANSONI

Article 12, Volume 50, Issue 3, Autumn 2020, Page 565-574  XML PDF (1.52 MB)
Document Type: Original Article
DOI: 10.12816/jesp.2020.131088
Authors
DINA I. ELGENDY1; AHMAD A. OTHMAN1; DINA M. EL-GUINDY2; NEMA A. SOLIMAN3; DALIA A. ELMEHY1
1Department of Medical Parasitology
2Department of Pathology
3Department of Medical Biochemistry
Abstract
Praziquantel can develop resistance and cannot counteract schistosomiasis pathology. β-glucan
was used as an immunomodulator for innate and acquired immunity. This study evaluated the
effects of β-glucan either alone or with PZQ on chronic Schistosoma mansoni infection. Mice
were divided into five groups: uninfected control, infected untreated, PZQ treated, β-glucan
treated and combined treatment groups. Treatment started at the end of 8th week P.I. Parasitological,
histopathological, immunohistochemical (α-SMA) studies and biochemical assays (Myeloperoxidase
activity, NO, TNF-α, INF-γ, IL-13 & hydroxyproline) in liver tissues were done.
Combination of β-glucan and PZQ therapy resulted in significant decrease in adults count, hepatic
egg loads, granuloma number and diameter as well as significant improvement of hepatic
pathology and reduction of hepatic fibrosis.
Keywords
Schistosoma mansoni; β-1; 3-glucan; NO; Alpha smooth muscle actin; TNF-α; INF- γ; Hepatic fibrosis
Statistics
Article View: 21
PDF Download: 46
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.